Symptoms of the Lower Urinary Tract Associated With COVID-19
DOI:
https://doi.org/10.54212/27068048.v10i2.135Keywords:
Covid-19, Hiperactive bladder, Cystitis Associated with CovidAbstract
INTRODUCTION: In 2019, the outbreak of Coronavirus Disease (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) 1 infection quickly altered global health systems and changed the dynamics of life worldwide. Beyond the respiratory system, studies have recently suggested that the virus may target the lower urinary tract due to the presence of ACE2 receptors on urothelial cells 4. OBJECTIVE: This review aims to show the currently available literature data on lower urinary tract symptoms in patients with SARS-COV-2 infection, to provide a timely overview, and to develop a desire for further studies and research on the topic. MATERIAL AND METHODS: In the present article, an analysis of publications about the alterations generated by COVID in the urinary tract is carried out. RESULTS: In the urinary tract, an inflammatory picture of the bladder urothelium is generated, generating what is known as CAC (Cystitis Associated with Covid) 1. DISCUSSION: Although the genitourinary system is not considered among the systems most affected by COVID-19, it is of utmost importance that urologists consider the evidence around the world of urinary symptoms in patients with SARS-COV-2. CONCLUSIONS: The data highlighted in this review demonstrate that patients with COVID-19 present signs and symptoms indicative of bladder hyperactivity. In addition, urinary symptoms may occur during the prodromal and post-COVID periods.
Downloads
References
Lamb LE, Dhar N, Timar R, Wills M, Dhar S, Chancellor MB. COVID-19 inflammation results in urine cytokine elevation and causes COVID-19 associated cystitis (CAC). Med Hypotheses. 2020 Dec;145:110375. https://doi.org/10.1016/j.mehy.2020.110375 DOI: https://doi.org/10.1016/j.mehy.2020.110375
Urogenital System Damaging Manifestations of 3 Human Infected Coronaviruses Zilin Wang, Daming Wang, Yuqian Dai, Sha Zhu and Hao Zeng.
Bourgonje AR, Abdulle AE, Timens W, Hillebrands JL, Navis GJ, Gordijn SJ, Bolling MC, Dijkstra G, Voors AA, Osterhaus AD, van der Voort PH, Mulder DJ, van Goor H. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol. 2020 Jul;251(3):228-248. https://doi.org/10.1002/path.5471 DOI: https://doi.org/10.1002/path.5471
Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single‐cell RNA‐seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019‐nCoV infection. Front Med. 2020;14(2):185‐192. https://doi.org/10.1007/s11684-020-0754-0 DOI: https://doi.org/10.1007/s11684-020-0754-0
Lamb, L.E., Timar, R., Wills, M. et al. Long COVID and COVID-19-associated cystitis (CAC). Int Urol Nephrol 54, 17-21 (2022). https://doi.org/10.1007/s11255-021-03030-2 DOI: https://doi.org/10.1007/s11255-021-03030-2
Kaya Y, Kaya C, Kartal T, Tahta T, Tokgöz VY. Could LUTS be early symptoms of COVID-19. Int J Clin Pract. 2021 Mar;75(3):e13850. https://doi.org/10.1111/ijcp.13850 DOI: https://doi.org/10.1111/ijcp.13850
Khaliq, Fareea & Wills, Melissa & Dhar, Nivedita & Bitar, Ali & Dhar, Sorabh & Komnenov, Dragana & Chancellor, Michael & Timar, Ryan & Lucas, Steven. (2021). Assessment Of Overactive Bladder Symptoms In Deconditioned Patients Recovering From Post-Acute Covid-19 Syndrome. Journal of Urology. 206. https://doi.org/10.1097/JU.0000000000001963.17 DOI: https://doi.org/10.1097/JU.0000000000001963.17
Zachariou A, Sapouna V, Kaltsas A, Dimitriadis F, Douvli E, Champilomatis I, Kounavou C, Papatsoris A, Tsounapi P, Takenaka A, Sofikitis N. Evaluation of Overactive Bladder Symptoms in Patients Recovering from Post-Acute COVID-19 Syndrome. J Multidiscip Healthc. 2022 Oct 26;15:2447-2452. https://doi.org/10.2147/JMDH.S384436 DOI: https://doi.org/10.2147/JMDH.S384436
New or worsening overactive bladder symptoms after recovery from COVID-19; Chen, W.; Komnenov, D.; Timar, R.; Wills, M.; Dhar, S.; Dhar, N..Journal of Urology ; 206(SUPPL 3):e1101-e1102, 2021. https://doi.org/10.1097/JU.0000000000002103.02 DOI: https://doi.org/10.1097/JU.0000000000002103.02
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Sergio Durán Ortíz, Marielle García Limas y Juan José Tequianes Tlalolín
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
